» Articles » PMID: 31747364

Potassium Sensitivity Test Predicts Hydrodistention Efficacy in Patients with Bladder Pain Syndrome/interstitial Cystitis

Overview
Journal Turk J Urol
Publisher Aves
Date 2019 Nov 21
PMID 31747364
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the possible role of potassium sensitivity test (PST) in predicting the success of hydrodistention (HD) in patients with bladder pain syndrome/interstitial cystitis (BPS/IC).

Material And Methods: Patients who underwent PST before diagnostic cystoscopy and HD were evaluated to collect data regarding the visual analog score (VAS) to assess pain, the voiding diary for frequency of urination/nocturia, mean urine volume per void, interstitial cystitis symptom index, and problem index before HD. Patients were requested to provide the VAS of pain at 1 month and 6 months post-HD. A reduction 2 or more on the VAS of pain was considered as a response adequate to be noted.

Results: The median age of the patients was 46 years. The PST was positive for 27 patients (27/39; 69.2%). At 1 month post-HD, out of the 27 patients with positive PST, 23 (85.2%) were found to have been responsive to HD and 4 (14.8%) were non-responsive. Of the 12 (12/39; 30.8%) patients who showed a negative PST, 7 (58.3%) were non-responsive and 5 (41.7%) were responsive to HD. A logistic regression analysis revealed that PST (p=0.009) was the only parameter that was able to predict HD efficacy at 1 month post-HD.

Conclusion: PST was found to be a predictive factor for the short-term efficacy of HD. BPS/IC patients with positive PST are likely to be more susceptible to the damage of mucosal afferent nerve endings, which results in them benefiting from HD to a greater degree.

Citing Articles

Diagnostic and therapeutic cystoscopy in bladder pain syndrome/interstitial cystitis: systematic review of literature and consensus on methodology.

Taneja R, Pandey S, Priyadarshi S, Goel A, Jain A, Sharma R Int Urogynecol J. 2023; 34(6):1165-1173.

PMID: 36708406 DOI: 10.1007/s00192-023-05449-w.


Virtual measurements of paracellular permeability and chronic inflammation via color coded pixel-wise T mapping.

Singh N, Zabbarova I, Ikeda Y, Maranchie J, Chermansky C, Foley L Am J Physiol Renal Physiol. 2020; 319(3):F506-F514.

PMID: 32715761 PMC: 7509285. DOI: 10.1152/ajprenal.00025.2020.

References
1.
Rovner E, Propert K, Brensinger C, Wein A, Foy M, Kirkemo A . Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group. Urology. 2000; 56(6):940-5. DOI: 10.1016/s0090-4295(00)00845-1. View

2.
Dunn M, Ramsden P, ROBERTS J, Smith J, Smith P . Interstitial cystitis, treated by prolonged bladder distension. Br J Urol. 1977; 49(7):641-5. DOI: 10.1111/j.1464-410x.1977.tb04545.x. View

3.
Berry S, Elliott M, Suttorp M, Bogart L, Stoto M, Eggers P . Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol. 2011; 186(2):540-4. PMC: 3513327. DOI: 10.1016/j.juro.2011.03.132. View

4.
Engeler D, Baranowski A, Dinis-Oliveira P, Elneil S, Hughes J, Messelink E . The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development. Eur Urol. 2013; 64(3):431-9. DOI: 10.1016/j.eururo.2013.04.035. View

5.
Erickson D, Kunselman A, Bentley C, Peters K, Rovner E, Demers L . Changes in urine markers and symptoms after bladder distention for interstitial cystitis. J Urol. 2007; 177(2):556-60. PMC: 2373609. DOI: 10.1016/j.juro.2006.09.029. View